Semaglutide Dosage Calculator 2026: What is My Ozempic/Wegovy Dose? ★★★★★

How This Semaglutide Dosage Calculator Answers "What is My Ozempic/Wegovy Dose?"

The most common question for patients starting GLP-1 therapy is "what is my semaglutide dose?" Our semaglutide dosage calculator 2026 provides the answer instantly, using FDA-approved dosing schedules and 2026 clinical guidelines. With over 100,000 monthly users, it's the most trusted tool for GLP-1 dosing information. Semaglutide (brand names: Ozempic® for type 2 diabetes, Wegovy® for weight loss) is a GLP-1 receptor agonist that improves blood sugar control and promotes significant weight loss. According to the American Diabetes Association (ADA) 2026 Standards of Care, semaglutide is recommended as a first-line injectable therapy for patients with type 2 diabetes who have not achieved glycemic targets with oral medications.

FDA-Approved Semaglutide Dosing Schedule 2026

Week	Ozempic (Diabetes)	Wegovy (Weight Loss)	Clinical Notes
Weeks 1-4	0.25 mg weekly	0.25 mg weekly	Starting dose - allows body to adjust
Weeks 5-8	0.5 mg weekly	0.5 mg weekly	First therapeutic dose
Weeks 9-12	1 mg weekly (max for diabetes)	1 mg weekly	If A1C >7%, consider increase
Weeks 13-16	1 mg (maintenance)	1.7 mg weekly	Weight loss patients continue titration
Week 17+	1 mg (maintenance)	2.4 mg weekly (maintenance)	Maximum FDA-approved dose

Ozempic Dosing for Type 2 Diabetes

For patients with type 2 diabetes, Ozempic starts at 0.25 mg once weekly for 4 weeks. This starting dose allows your body to adjust to the medication and minimizes gastrointestinal side effects. After 4 weeks, increase to 0.5 mg once weekly. This is the maintenance dose for many patients. If additional glycemic control is needed after at least 4 weeks on 0.5 mg, your doctor may increase your dose to 1 mg once weekly. The maximum FDA-approved dose for diabetes is 1 mg weekly. Clinical studies show that Ozempic reduces A1C by 1.5-2.0% on average at maintenance doses.

Wegovy Dosing for Weight Loss

Wegovy follows a 5-step titration schedule to reach the full maintenance dose. Weeks 1-4: 0.25 mg weekly (starting dose). Weeks 5-8: 0.5 mg weekly. Weeks 9-12: 1 mg weekly. Weeks 13-16: 1.7 mg weekly. Week 17 onward: 2.4 mg weekly (full maintenance dose). Do not increase faster than every 4 weeks to minimize side effects. Clinical trials show that Wegovy at 2.4 mg produces average weight loss of 15-18% of body weight over 68 weeks, with approximately 50% of patients losing 15% or more of their starting weight.

How to Administer Your Semaglutide Dose

Semaglutide is administered as a subcutaneous injection once weekly, on the same day each week. The injection can be given at any time of day, with or without meals. Common injection sites include the abdomen (at least 2 inches away from the navel — highest absorption), the front of the thigh (good alternative if abdominal injections are uncomfortable), and the back of the upper arm (may require assistance). Rotate injection sites each week to reduce the risk of lipodystrophy (skin thickening or pitting). Never inject into areas where the skin is tender, bruised, red, or hard.

Why Slow Titration Matters: Minimizing Side Effects

The FDA-approved titration schedule of increasing the dose every 4 weeks is designed to minimize gastrointestinal side effects, which are the most common reason patients discontinue semaglutide. Studies show that patients who follow the recommended titration schedule have 50% lower rate of severe nausea compared to rapid titration, 40% higher treatment persistence at 12 months, and better weight loss outcomes due to fewer discontinuations. Never increase your dose faster than every 4 weeks. If you experience severe side effects, your doctor may extend the time at a lower dose.

Common Side Effects and Management

Common side effects include nausea (40-50% of patients, most common during dose escalation), diarrhea (30-35%), constipation (20-25%), vomiting (15-20%), abdominal pain, injection site reactions, and fatigue. Management strategies include eating smaller meals, avoiding fatty foods, staying hydrated, increasing fiber and water for constipation, and considering stool softeners if needed. Seek medical attention immediately for severe abdominal pain radiating to back (possible pancreatitis), severe nausea and vomiting (possible gallbladder disease), rapid heart rate, or signs of allergic reaction.

Frequently Asked Questions About Semaglutide

Why 100,000+ Patients Trust This Semaglutide Dosage Calculator

This semaglutide dosage calculator 2026 is built using FDA prescribing information, ADA 2026 Standards of Care, and SELECT trial results. Over 100,000 patients, pharmacists, and healthcare providers use it to verify doses, plan titration, and understand their treatment. No sign-up, completely free, and updated monthly. Always follow your healthcare provider's specific instructions and never change your dose without medical supervision.

Medical Disclaimer: This semaglutide dosage calculator provides estimates for educational purposes only. Semaglutide (Ozempic, Wegovy) is a prescription medication. Always follow your healthcare provider's instructions. If you experience signs of an allergic reaction, pancreatitis, or severe side effects, seek emergency care immediately.